Proliferation and apoptosis as markers of benefit in neoadjuvant endocrine therapy of breast cancer.
Dowsett M, Smith IE, Ebbs SR, Dixon JM, Skene A, Griffith C, Boeddinghaus I, Salter J, Detre S, Hills M, Ashley S, Francis S, Walsh G, A'Hern R.
Dowsett M, et al.
Clin Cancer Res. 2006 Feb 1;12(3 Pt 2):1024s-1030s. doi: 10.1158/1078-0432.CCR-05-2127.
Clin Cancer Res. 2006.
PMID: 16467120
Free article.
Clinical Trial.